2018-2019 Drug Updates in Hematologic Malignancies.
J Adv Pract Oncol
; 11(3): 249-253, 2020 Apr.
Article
em En
| MEDLINE
| ID: mdl-33598320
ABSTRACT
Lauren Held, PharmD, BCOP, updated attendees on the FDA-approved therapies for initial or expanded indications for hematologic malignancies across the past year, as well as their supporting clinical trial data and best practices for safe and effective dosing and administration, drug monitoring, and adverse event management.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Guideline
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article